XENE
XENE
NASDAQ · Biotechnology

Xenon Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$39.75
-17.60 (-30.69%)
XENE News1 articles
Xenon Pharma Stock Plunges 31% on Psychiatry Trial Halt
Xenon Pharmaceuticals shares tumbled 30.7% after pausing enrollment in depression studies due to neuropsychiatric adverse events, overshadowing its FDA filing for azetukalner in epilepsy.
Analysis